홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

3-[2-(1-Piperazinyl)ethyl]-2-oxazolidinone → 3-[2-[4-{10,11-Dihydro-2-dimethylsulphamoyl-dibenzo[b,f]thiepin-10-yl}-1-piperazinyl]-ethyl]-2-oxazolidinone

HRID 435708
인쇄

반응식

HRID 435708 반응식
Cl[CH:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[S:6][C:5]2[CH:13]=[CH:14][C:15]([S:17](=[O:22])(=[O:21])[N:18]([CH3:20])[CH3:19])=[CH:16][C:4]=2[CH2:3]1.[N:23]1([CH2:29][CH2:30][N:31]2[CH2:35][CH2:34][O:33][C:32]2=[O:36])[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]1>C(Cl)(Cl)Cl>[CH3:19][N:18]([CH3:20])[S:17]([C:15]1[CH:14]=[CH:13][C:5]2[S:6][C:7]3[CH:12]=[CH:11][CH:10]=[CH:9][C:8]=3[CH:2]([N:26]3[CH2:27][CH2:28][N:23]([CH2:29][CH2:30][N:31]4[CH2:35][CH2:34][O:33][C:32]4=[O:36])[CH2:24][CH2:25]3)[CH2:3][C:4]=2[CH:16]=1)(=[O:22])=[O:21]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 122755453-[2-(1-Piperazinyl)ethyl]-2-oxazolidinoneHCID 1561900510-Chloro-10,11-dihydro-2-dimethylsulphamoyl-dibenzo[b,f]thiepin

생성물 1

HCID 214811443-[2-[4-{10,11-Dihydro-2-dimethylsulphamoyl-dibenzo[b,f]thiepin-10-yl}-1-piperazinyl]-ethyl]-2-oxazolidinone

시약·촉매·용매 1

HCID 6212Chloroform용매

실험 절차

11.9 g of 10-chloro-10,11-dihydro-2-dimethylsulphamoyldibenzo[b,f]thiepin in 250 ml of chloroform are treated with 20 g of 3-[2-(1-piperazinyl)-ethyl]-2-oxazolidinone and the mixture is heated under reflux for 24 hours. Then the mixture is evaporated under reduced pressure and the residue taken up in ethyl acetate. The organic phase is washed with water, dried over magnesium sulphate and evaporated under reduced pressure. The residue is dissolved in benzene and filtered through a column filled with 100 g of aluminium oxide (activity stage II). The eluate is evaporated and, for the purpose of further purification, chromatographed on 75 g of silicagel (0.2-0.5 mm), elution being effected with a 1:1 mixture of chloroform saturated with concentrated ammonia/carbon tetrachloride. The purified product is recrystallised from ethyl acetate/petroleum ether. There is obtained 3-[2-[4-{10,11-dihydro-2-dimethylsulphamoyl-dibenzo[b,f]thiepin-10-yl}-1-piperazinyl]-ethyl]-2-oxazolidinone which melts at 164°-165° C.

후처리

  1. temperaturethe mixture is heated
  2. temperatureunder reflux for 24 hours
  3. customThen the mixture is evaporated under reduced pressure
  4. washThe organic phase is washed with water
  5. dry with materialdried over magnesium sulphate
  6. customevaporated under reduced pressure
  7. dissolutionThe residue is dissolved in benzene
  8. filtrationfiltered through a column
  9. additionfilled with 100 g of aluminium oxide (activity stage II)
  10. customThe eluate is evaporated and, for the purpose of further purification
  11. customchromatographed on 75 g of silicagel (0.2-0.5 mm), elution
  12. additionbeing effected with a 1:1 mixture of chloroform saturated with concentrated ammonia/carbon tetrachloride
  13. customThe purified product is recrystallised from ethyl acetate/petroleum ether

출처 및 근거

ORD 기록
ord-7e5b5f3626c74bcea0cb90522e4e4c86
출처 데이터셋
uspto-grants-1977_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04006144

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트